Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME (UNAUDITED)

v3.22.2.2
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME (UNAUDITED) - CAD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Profit or loss [abstract]        
Revenues $ 23,821 $ 11,112 $ 47,390 $ 19,879
Cost of revenues 18,208 10,510 35,423 14,650
Gross profit before fair value adjustments 5,613 602 11,967 5,229
Fair value adjustments:        
Unrealized change in fair value of biological assets 56 2,018 1,135 4,361
Realized fair value adjustments on inventory sold in the period (1,654) (3,188) (2,517) (5,130)
Total fair value adjustments (1,598) (1,170) (1,382) (769)
Gross profit (loss) 4,015 (568) 10,585 4,460
General and administrative expenses 11,184 7,475 20,226 12,388
Selling and marketing expenses 5,026 1,301 8,746 2,491
Restructuring expenses 5,415 0 9,162 0
Share-based compensation 1,048 1,373 2,658 2,003
Total operating expenses 22,673 10,149 40,792 16,882
Operating loss (18,658) (10,717) (30,207) (12,422)
Finance income 3,206 6,208 6,097 13,434
Finance expense (4,591) (543) (6,927) (846)
Finance income (expenses), net (1,385) 5,665 (830) 12,588
Loss from disposal of investment (114) 0 (114) 0
Income (loss) before income taxes (20,157) (5,052) (31,151) 166
Income tax expense (benefit) (1,179) 37 (1,432) 540
Net Loss (18,978) (5,089) (29,719) (374)
Other comprehensive income (loss) that will not be reclassified to profit or loss in subsequent periods:        
Exchange differences on translation to presentation currency (1,150) 152 (2,942) (1,238)
Other comprehensive income that will be reclassified to profit or loss in subsequent periods:        
Adjustments arising from translating financial statements of foreign operation 345 27 1,203 259
Total other comprehensive income (loss) (805) 179 (1,739) (979)
Total comprehensive loss (19,783) (4,910) (31,458) (1,353)
Net loss attributable to:        
Equity holders of the Company (18,665) (4,630) (28,117) (125)
Non-controlling interests (313) (459) (1,602) (249)
Net loss (18,978) (5,089) (29,719) (374)
Total comprehensive loss attributable to:        
Equity holders of the Company (19,437) (4,459) (29,727) (1,123)
Non-controlling interests (346) (451) (1,731) (230)
Total comprehensive loss $ (19,783) $ (4,910) $ (31,458) $ (1,353)
Loss per share attributable to equity holders of the Company:        
Basic loss per share (in CAD) $ (0.27) $ (0.1) $ (0.4) $ 0
Diluted loss per share (in CAD) $ (0.3) $ (0.23) $ (0.47) $ (0.28)